在前列腺癌中准糖解:分子机制和治疗进展
Jiexiang Zhang1, Tongtong Zhang1, Dexin Song1
1Urology Centre, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Surgical Institute of Integrative Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Surgical Institute, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai 201203, China.
前列腺癌 (PCa) 的进展涉及改变的葡萄糖分解,这是一个对瘤生长和抵抗至关重要的代谢过程. 向癌症糖解提供了改善PCa管理的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 癌症研究 癌症研究
背景情况:
- 前列腺癌 (PCa) 是全球男性癌症死亡的主要原因.
- 代谢重编程,特别是增强的葡萄糖分解,是PCa进展的标志.
- 异常的葡萄糖溶解推动了PCa的扩散,转移和对治疗的抵抗.
研究的目的:
- 审查糖解在前列腺癌中的关键作用.
- 讨论关键的糖解酶及其在PCa中的调节.
- 探索针对PCa糖解的当前和未来治疗策略.
主要方法:
- 对前列腺癌新陈代谢研究的文献综述.
- 分析关键的糖解酶 (HK2,PFK,PKM2,GLUTs,LDHA) 的作用.
- 对调控机制的检查 (PI3K/AKT,AMPK,HIF-1α,c-Myc,非编码RNAs).
主要成果:
- 糖解在PCa中显著上调,支持瘤生长和存活.
- 特定的酶和调节途径对于PCa细胞中的有氧糖解至关重要.
- 向葡萄糖溶解显示出作为PCa的治疗方法的希望.
结论:
- 向癌细胞糖解是一种新型PCa疗法的有希望的策略.
- 对代谢干预的进一步研究可以克服目前PCa治疗的局限性.
- 了解PCa代谢重编程是制定精确治疗策略的关键.
相关概念视频
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
07:16Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
06:48An Orthotopic Murine Model of Human Prostate Cancer Metastasis
09:11Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:43Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
08:03Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells


